Recent study reported insulin modulates clearance of Aβ through its effects on lipid metabolism and proteases, and peripheral insulin resistance might precede Aβ accumulation, as the pathological processes of Alzheimer's disease. This evidence concerns the gene INS and early-onset autosomal dominant Alzheimer disease.